90 related articles for article (PubMed ID: 8425590)
1. Restrictive treatment policy for pulmonary tuberculosis in a low prevalence country.
Nørregaard J; Grode G; Viskum K
Eur Respir J; 1993 Jan; 6(1):23-6. PubMed ID: 8425590
[TBL] [Abstract][Full Text] [Related]
2. [Should the presence of Mycobacterium tuberculosis be demonstrated before the treatment of patients with suspected pulmonary tuberculosis?].
Nørregaard J; Grode GW; Viskum K
Ugeskr Laeger; 1994 Sep; 156(37):5276-8. PubMed ID: 7941064
[TBL] [Abstract][Full Text] [Related]
3. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
Tiwari S; Kumar A; Kapoor SK
Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of tuberculosis cases detected in our region between 1999 and 2003].
Ozbay B; Sezgi C; Altinöz O; Sertoğullarindan B; Tokgöz N
Tuberk Toraks; 2008; 56(4):396-404. PubMed ID: 19123075
[TBL] [Abstract][Full Text] [Related]
6. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
Kliiman K; Altraja A
Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
[TBL] [Abstract][Full Text] [Related]
7. [Death due to tuberculosis requiring treatment or an accompanying disease? A contribution to the lethality and mortality of tuberculosis in Germany].
Forssbohm M; Kropp R; Loytved G; Neher A; Simma M; Rabbow M; Becher H
Pneumologie; 2011 Oct; 65(10):607-14. PubMed ID: 22015487
[TBL] [Abstract][Full Text] [Related]
8. Delay in the diagnosis and treatment of pulmonary tuberculosis in patients attending a university teaching hospital.
Liam CK; Tang BG
Int J Tuberc Lung Dis; 1997 Aug; 1(4):326-32. PubMed ID: 9432388
[TBL] [Abstract][Full Text] [Related]
9. [Tuberculosis in Poland 2000--at the turn of the century].
Szczuka I
Pneumonol Alergol Pol; 2002; 70(3-4):155-66. PubMed ID: 12271963
[TBL] [Abstract][Full Text] [Related]
10. An epidemiological study of multi drug resistant tuberculosis cases registered under Revised National Tuberculosis Control Programme of Ahmedabad City.
Bhatt G; Vyas S; Trivedil K
Indian J Tuberc; 2012 Jan; 59(1):18-27. PubMed ID: 22670507
[TBL] [Abstract][Full Text] [Related]
11. [Clinical, epidemiological and microbiological characteristics of a cohort of pulmonary tuberculosis patients in Cali, Colombia].
Rojas CM; Villegas SL; Piñeros HM; Chamorro EM; Durán CE; Hernández EL; Pacheco R; Ferro BE
Biomedica; 2010; 30(4):482-91. PubMed ID: 21713351
[TBL] [Abstract][Full Text] [Related]
12. Smear-negative pulmonary tuberculosis.
Dutt AK; Stead WW
Semin Respir Infect; 1994 Jun; 9(2):113-9. PubMed ID: 7973170
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
[TBL] [Abstract][Full Text] [Related]
14. [Tuberculosis in Poland in 2003].
Szczuka I
Przegl Epidemiol; 2005; 59(2):353-61. PubMed ID: 16190542
[TBL] [Abstract][Full Text] [Related]
15. Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort study.
Vree M; Huong NT; Duong BD; Sy DN; Van le N; Co NV; Cobelens FG; Borgdorff MW
BMC Public Health; 2007 Jul; 7():134. PubMed ID: 17605770
[TBL] [Abstract][Full Text] [Related]
16. Five year review of treatment outcome of directly observed therapy (DOT) for re-treatment pulmonary tuberculosis patients in UCH, Ibadan, Nigeria.
Ige OM; Akindele MO
Afr J Med Med Sci; 2011 Mar; 40(1):15-21. PubMed ID: 21834257
[TBL] [Abstract][Full Text] [Related]
17. Mortality among tuberculosis patients in the Democratic Republic of Congo.
Henegar C; Behets F; Vanden Driessche K; Tabala M; Bahati E; Bola V; Van Rie A
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1199-204. PubMed ID: 22871326
[TBL] [Abstract][Full Text] [Related]
18. Delay in tuberculosis diagnosis and treatment in four provinces of Argentina.
Zerbini E; Chirico MC; Salvadores B; Amigot B; Estrada S; Algorry G
Int J Tuberc Lung Dis; 2008 Jan; 12(1):63-8. PubMed ID: 18173879
[TBL] [Abstract][Full Text] [Related]
19. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
[TBL] [Abstract][Full Text] [Related]
20. 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence.
Hargreaves NJ; Kadzakumanja O; Whitty CJ; Salaniponi FM; Harries AD; Squire SB
Int J Tuberc Lung Dis; 2001 Sep; 5(9):847-54. PubMed ID: 11573897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
